Cargando…
Association between proton pump inhibitor use and the risk of pancreatic cancer: A Korean nationwide cohort study
PURPOSE: Proton pump inhibitor (PPI) therapy causes hypergastrinemia, which could promote the development and progression of pancreatic cancer. Accordingly, this study aimed to investigate the association between PPI exposure and the risk of pancreatic cancer. METHODS: We conducted a twelve-year lon...
Autores principales: | Hwang, In Cheol, Chang, Jooyoung, Park, Sang Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135510/ https://www.ncbi.nlm.nih.gov/pubmed/30208110 http://dx.doi.org/10.1371/journal.pone.0203918 |
Ejemplares similares
-
Emerging hazard effects of proton pump inhibitor on the risk of colorectal cancer in low-risk populations: A Korean nationwide prospective cohort study
por: Hwang, In Cheol, et al.
Publicado: (2017) -
Association between Proton Pump Inhibitor Use and Risk of Hepatocellular Carcinoma: A Korean Nationally Representative Cohort Study
por: Kim, Soungmun, et al.
Publicado: (2022) -
Aspirin Use and Risk of Hepatocellular Carcinoma in a National Cohort Study of Korean Adults
por: Hwang, In Cheol, et al.
Publicado: (2018) -
Proton Pump Inhibitors Increase the Risk of Autoimmune Diseases: A Nationwide Cohort Study
por: Lin, Sheng-Hong, et al.
Publicado: (2021) -
Associations between proton pump inhibitors and Alzheimer’s disease: a nested case–control study using a Korean nationwide health screening cohort
por: Choi, Hyo Geun, et al.
Publicado: (2022)